scispace - formally typeset
G

Geert R. Verheyen

Researcher at Thomas More College

Publications -  18
Citations -  321

Geert R. Verheyen is an academic researcher from Thomas More College. The author has contributed to research in topics: In vivo & Liver injury. The author has an hindex of 10, co-authored 18 publications receiving 262 citations. Previous affiliations of Geert R. Verheyen include Janssen Pharmaceutica.

Papers
More filters
Journal ArticleDOI

Evaluation of miR-122 and Other Biomarkers in Distinct Acute Liver Injury in Rats

TL;DR: The response of miR-122 paralleled that of other markers and was consistent with liver injury as indicated by histopathological evaluation and changed earlier than standard liver injury markers and exhibited a wide dynamic range.
Journal ArticleDOI

Oxidative stress/reactive metabolite gene expression signature in rat liver detects idiosyncratic hepatotoxicants.

TL;DR: The liver RNA samples from drug-treated rats from more recent experiments were examined for statistical fit to the OS/RM signature, and nine drugs linked to idiosyncratic hepatotoxicity of drug candidates were identified.
Journal ArticleDOI

Phospholipidosis in Rats Treated with Amiodarone: Serum Biochemistry and Whole Genome Micro-Array Analysis Supporting the Lipid Traffic Jam Hypothesis and the Subsequent Rise of the Biomarker BMP

TL;DR: Modulation indicates that during phospholipidosis-induction interactions take place between the cationic amphiphilic drug andospholipids at the level of BMP-rich internal membranes of endosomes, impeding cholesterol sorting and leading to an accumulation of internal membranes, converting into multilamellar bodies.
Journal ArticleDOI

Screening for phospholipidosis induced by central nervous drugs: Comparing the predictivity of an in vitro assay to high throughput in silico assays

TL;DR: By considering the proposed plasma concentration at the efficacious dose, the in vitro low throughput assay is preferred above high throughput in silico assays, characterized by a high false positive rate.
Journal ArticleDOI

Automated analysis of contractility in the embryonic stem cell test, a novel approach to assess embryotoxicity.

TL;DR: The automated image recording of contractile cardiomyocyte-like cells in the EST allows for an unbiased high throughput method to assess the embryotoxic potency of test compounds, resulting in an outcome comparable to manual analysis.